|
|
Article: PCa at end of biopsy core a bad sign: extracapsular extension found in nearly 60% of men with tumor cells at the end of a needle core.
- Article from:
- Renal & Urology News
- Article date:
- June 1, 2008
- Author:
CopyrightCOPYRIGHT 2008 Haymarket Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DENVER -- The presence of tumor cells at the end of a needle biopsy core obtained near the capsule is an independent indicator of a significantly elevated risk of extracapsular extension, according to data presented here at the annual meeting of the United States and Canada Academy of Pathology.
In a study of 185 men who underwent radical prostatectomies who were available for tumor-stage follow-up, Kirk Ke Lin, MD, director of genitourinary pathology at AmeriPath, Inc., discovered that 50.9% of cases with cancerous cells in the end of the needle core near the capsule had stage pT3a or pT3b prostate cancer compared with just 16.2 % of cases that did not have ...